Shanghai Kindly Medical Posts Double-Digit Profit Growth on Rising Interventional Device Sales

The latest update is out from Shanghai Kindly Medical Instruments Co., Ltd. Class H ( (HK:1501) ).

Shanghai Kindly Medical Instruments Co., Ltd. reported strong growth for the year ended 31 December 2025, with revenue rising 25.06% year on year to RMB1.07 billion, driven by an expanded customer base and business combinations. Sales of interventional medical devices increased by a similar margin to RMB967.95 million, underscoring the company’s core focus on this segment.

Gross profit climbed to RMB636.79 million, although the overall gross margin slipped from 63.11% to 59.77%, reflecting some pressure on profitability even as volumes grew. Net profit rose 22.43% to RMB232.67 million, and earnings per share improved to RMB1.26, while the board recommended a final dividend of RMB0.23 per share, signaling management’s confidence and providing a direct return to shareholders.

The most recent analyst rating on (HK:1501) stock is a Buy with a HK$35.00 price target. To see the full list of analyst forecasts on Shanghai Kindly Medical Instruments Co., Ltd. Class H stock, see the HK:1501 Stock Forecast page.

More about Shanghai Kindly Medical Instruments Co., Ltd. Class H

Shanghai Kindly Medical Instruments Co., Ltd. is a PRC-based medical device manufacturer focused on interventional medical instruments. The group generates the bulk of its revenue from sales of interventional medical devices, targeting hospitals and healthcare providers seeking minimally invasive treatment solutions.

Average Trading Volume: 196,566

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$6.56B

For a thorough assessment of 1501 stock, go to TipRanks’ Stock Analysis page.